FDA Warning about a Fraudulent COVID-19 Product

U.S. Food and Drug Administration sent this bulletin at 11/08/2022 02:07 PM EST

Subscribe

FDA | Center for Drug Evaluation and Research | Office of Compliance

Medication Health Fraud Update

The FDA recently issued a warning letter jointly with the Federal Trade Commission to Alternative Health Distribution LLC d/b/a CannaAid for selling unapproved and misbranded products for use in treating or preventing COVID-19. Consumers concerned about COVID-19 should consult with their health care provider.

FDA is actively monitoring for any firms marketing products with fraudulent COVID-19 prevention and treatment claims.

Fraudulent COVID-19 Products

FDA's Health Fraud Product Database includes only a small fraction of the potentially dangerous products marketed to consumers online and in stores. Even if a product is not included in this list, consumers should exercise caution before using these types of products.

Learn More

FDA is providing this information to assist consumers, patients, and healthcare professionals in identifying health fraud. A health product is fraudulent if it is deceptively promoted as being effective against a disease or health condition, but not scientifically proven safe and effective for that purpose.